Higher expression of CCL2, CCL4, CCL5, CCL21, and CXCL8 chemokines in the skin associated with parasite density in canine visceral leishmaniasis

PLoS Neglected Tropical Diseases

Volumn 6, Issue 4, 2012, Pages

  Menezes Souza, Daniel ^a,b   Guerra Sá, Renata ^a   Carneiro, Cláudia Martins ^a,b   Vitoriano Souza, Juliana ^a   Giunchetti, Rodolfo Cordeiro ^a,b   Teixeira Carvalho, Andréa ^b   Silveira Lemos, Denise ^a   Oliveira, Guilherme Corrêa ^b   Corrêa Oliveira, Rodrigo ^b   Reis, Alexandre Barbosa ^a,b  

^a FEDERAL UNIVERSITY OF OURO PRETO   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; EOTAXIN; EOTAXIN 2; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 3; MONOCYTE CHEMOTACTIC PROTEIN 4; RANTES; SECONDARY LYMPHOID TISSUE CHEMOKINE; THYMUS AND ACTIVATION REGULATED CHEMOKINE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DERMIS; DISEASE COURSE; DNA SEQUENCE; DOG; EOSINOPHIL; FEMALE; HISTOLOGY; IMMUNE RESPONSE; INFLAMMATORY CELL; INFLAMMATORY INFILTRATE; LEISHMANIA DONOVANI; LEISHMANIA INFANTUM; LYMPHOCYTE; MACROPHAGE; MALE; MAST CELL; MONONUCLEAR CELL; NEUTROPHIL; NONHUMAN; NUCLEOTIDE SEQUENCE; PARASITE DENSITY; PARASITE LOAD; PARASITISM; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; VISCERAL LEISHMANIASIS; ANIMAL; ANIMAL DISEASE; BIOSYNTHESIS; DOG DISEASE; GENE EXPRESSION; IMMUNOLOGY; ISOLATION AND PURIFICATION; PATHOLOGY; SKIN;

ANIMALS; CHEMOKINES; DOG DISEASES; DOGS; FEMALE; GENE EXPRESSION; LEISHMANIA INFANTUM; LEISHMANIASIS, VISCERAL; MALE; REAL-TIME POLYMERASE CHAIN REACTION; SKIN;

EID: 84861203668     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0001566     Document Type: Article

References (55)

1. Desjeux P, (2004) Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis 27: 305-318.
2. Tesh RB, (1995) Control of zoonotic visceral leishmaniasis: is it time to change strategies? Am J Trop Med Hyg 52: 287-292.
3. Abranches P, Silva-Pereira MC, Conceicao-Silva FM, Santos-Gomes GM, Janz JG, (1991) Canine leishmaniasis: pathological and ecological factors influencing transmission of infection. J Parasitol 77: 557-561.
4. Giunchetti RC, Mayrink W, Genaro O, Carneiro CM, Correa-Oliveira R, et al. (2006) Relationship between canine visceral leishmaniosis and the Leishmania (Leishmania) chagasi burden in dermal inflammatory foci. J Comp Pathol 135: 100-107.
5. Chamizo C, Moreno J, Alvar J, (2005) Semi-quantitative analysis of cytokine expression in asymptomatic canine leishmaniasis. Vet Immunol Immunopathol 103: 67-75.
6. Reis AB, Martins-Filho OA, Teixeira-Carvalho A, Carvalho MG, Mayrink W, et al. (2006) Parasite density and impaired biochemical/hematological status are associated with severe clinical aspects of canine visceral leishmaniasis. Res Vet Sci 81: 68-75.
7. Reis AB, Teixeira-Carvalho A, Giunchetti RC, Guerra LL, Carvalho MG, et al. (2006) Phenotypic features of circulating leucocytes as immunological markers for clinical status and bone marrow parasite density in dogs naturally infected by Leishmania chagasi. Clin Exp Immunol 146: 303-311.
8. Reis AB, Teixeira-Carvalho A, Vale AM, Marques MJ, Giunchetti RC, et al. (2006) Isotype patterns of immunoglobulins: hallmarks for clinical status and tissue parasite density in Brazilian dogs naturally infected by Leishmania (Leishmania) chagasi. Vet Immunol Immunopathol 112: 102-116.
9. Lage RS, Oliveira GC, Busek SU, Guerra LL, Giunchetti RC, et al. (2007) Analysis of the cytokine profile in spleen cells from dogs naturally infected by Leishmania chagasi. Vet Immunol Immunopathol 115: 135-145.
10. Giunchetti RC, Martins-Filho OA, Carneiro CM, Mayrink W, Marques MJ, et al. (2008) Histopathology, parasite density and cell phenotypes of the popliteal lymph node in canine visceral leishmaniasis. Vet Immunol Immunopathol 121: 23-33.
11. Giunchetti RC, Mayrink W, Carneiro CM, Correa-Oliveira R, Martins-Filho OA, et al. (2008) Histopathological and immunohistochemical investigations of the hepatic compartment associated with parasitism and serum biochemical changes in canine visceral leishmaniasis. Res Vet Sci 84: 269-277.
12. Alves CF, de Amorim IF, Moura EP, Ribeiro RR, Michalick MS, et al. (2009) Expression of IFN-gamma, TNF-alpha, IL-10 and TGF-beta in lymph nodes associates with parasite load and clinical form of disease in dogs naturally infected with Leishmania (Leishmania) chagasi. Vet Immunol Immunopathol 128: 349-358.
13. Carrillo E, Moreno J, (2009) Cytokine profiles in canine visceral leishmaniasis. Vet Immunol Immunopathol 128: 67-70.
14. Guerra LL, Teixeira-Carvalho A, Giunchetti RC, Martins-Filho OA, Reis AB, et al. (2009) Evaluation of the influence of tissue parasite density on hematological and phenotypic cellular parameters of circulating leukocytes and splenocytes during ongoing canine visceral leishmaniasis. Parasitol Res 104: 611-622.
15. Manna L, Reale S, Vitale F, Gravino AE, (2009) Evidence for a relationship between Leishmania load and clinical manifestations. Res Vet Sci 87: 76-78.
16. Reis AB, Martins-Filho OA, Teixeira-Carvalho A, Giunchetti RC, Carneiro CM, et al. (2009) Systemic and compartmentalized immune response in canine visceral leishmaniasis. Vet Immunol Immunopathol 128: 87-95.
17. Menezes-Souza D, Correa-Oliveira R, Guerra-Sa R, Giunchetti RC, Teixeira-Carvalho A, et al. (2011) Cytokine and transcription factor profiles in the skin of dogs naturally infected by Leishmania (Leishmania) chagasi presenting distinct cutaneous parasite density and clinical status. Vet Parasitol 177: 39-49.
18. Baneth G, Koutinas AF, Solano-Gallego L, Bourdeau P, Ferrer L, (2008) Canine leishmaniosis- new concepts and insights on an expanding zoonosis: part one. Trends Parasitol 24: 324-330.
19. dos-Santos WL, David J, Badaro R, de-Freitas LA, (2004) Association between skin parasitism and a granulomatous inflammatory pattern in canine visceral leishmaniosis. Parasitol Res 92: 89-94.
20. Solano-Gallego L, Fernandez-Bellon H, Morell P, Fondevila D, Alberola J, et al. (2004) Histological and immunohistochemical study of clinically normal skin of Leishmania infantum-infected dogs. J Comp Pathol 130: 7-12.
21. Calabrese KS, Cortada VM, Dorval ME, Souza Lima MA, Oshiro ET, et al. (2010) Leishmania (Leishmania) infantum/chagasi: Histopathological aspects of the skin in naturally infected dogs in two endemic areas. Exp Parasitol 124: 253-257.
22. Correa AP, Dossi AC, de Oliveira Vasconcelos R, Munari DP, de Lima VM, (2007) Evaluation of transformation growth factor beta1, interleukin-10, and interferon-gamma in male symptomatic and asymptomatic dogs naturally infected by Leishmania (Leishmania) chagasi. Vet Parasitol 143: 267-274.
23. Panaro MA, Brandonisio O, Cianciulli A, Cavallo P, Lacasella V, et al. (2009) Cytokine expression in dogs with natural Leishmania infantum infection. Parasitology 136: 823-831.
24. Strauss-Ayali D, Baneth G, Jaffe CL, (2007) Splenic immune responses during canine visceral leishmaniasis. Vet Res 38: 547-564.
25. Mancianti F, Gramiccia M, Gradoni L, Pieri S, (1988) Studies on canine leishmaniasis control. 1. Evolution of infection of different clinical forms of canine leishmaniasis following antimonial treatment. Trans R Soc Trop Med Hyg 82: 566-567.
26. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, et al. (2009) The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 55: 611-622.
27. Sallusto F, Mackay CR, Lanzavecchia A, (2000) The role of chemokine receptors in primary, effector, and memory immune responses. Annu Rev Immunol 18: 593-620.
28. Ono SJ, Nakamura T, Miyazaki D, Ohbayashi M, Dawson M, et al. (2003) Chemokines: roles in leukocyte development, trafficking, and effector function. J Allergy Clin Immunol 111: 1185-1199; quiz 1200.
29. Ritter U, Moll H, Laskay T, Brocker E, Velazco O, et al. (1996) Differential expression of chemokines in patients with localized and diffuse cutaneous American leishmaniasis. J Infect Dis 173: 699-709.
30. Muzio M, Bosisio D, Polentarutti N, D'Amico G, Stoppacciaro A, et al. (2000) Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells. J Immunol 164: 5998-6004.
31. Dorner BG, Scheffold A, Rolph MS, Huser MB, Kaufmann SH, et al. (2002) MIP-1alpha, MIP-1beta, RANTES, and ATAC/lymphotactin function together with IFN-gamma as type 1 cytokines. Proc Natl Acad Sci U S A 99: 6181-6186.
32. Ji J, Sun J, Soong L, (2003) Impaired expression of inflammatory cytokines and chemokines at early stages of infection with Leishmania amazonensis. Infect Immun 71: 4278-4288.
33. Brandonisio O, Panaro MA, Fumarola I, Sisto M, Leogrande D, et al. (2002) Macrophage chemotactic protein-1 and macrophage inflammatory protein-1 alpha induce nitric oxide release and enhance parasite killing in Leishmania infantum-infected human macrophages. Clin Exp Med 2: 125-129.
34. Bhattacharyya S, Ghosh S, Dasgupta B, Mazumder D, Roy S, et al. (2002) Chemokine-induced leishmanicidal activity in murine macrophages via the generation of nitric oxide. J Infect Dis 185: 1704-1708.
35. Marsland BJ, Battig P, Bauer M, Ruedl C, Lassing U, et al. (2005) CCL19 and CCL21 induce a potent proinflammatory differentiation program in licensed dendritic cells. Immunity 22: 493-505.
36. Ato M, Nakano H, Kakiuchi T, Kaye PM, (2004) Localization of marginal zone macrophages is regulated by C-C chemokine ligands 21/19. J Immunol 173: 4815-4820.
37. Ato M, Maroof A, Zubairi S, Nakano H, Kakiuchi T, et al. (2006) Loss of dendritic cell migration and impaired resistance to Leishmania donovani infection in mice deficient in CCL19 and CCL21. J Immunol 176: 5486-5493.
38. Katakura K, Saito S, Hamada A, Matsuda H, Watanabe N, (1993) Cutaneous leishmaniasis in mast cell-deficient W/Wv mice. Infect Immun 61: 2242-2244.
39. Wershil BK, Theodos CM, Galli SJ, Titus RG, (1994) Mast cells augment lesion size and persistence during experimental Leishmania major infection in the mouse. J Immunol 152: 4563-4571.
40. Maurer M, Lopez Kostka S, Siebenhaar F, Moelle K, Metz M, et al. (2006) Skin mast cells control T cell-dependent host defense in Leishmania major infections. FASEB J 20: 2460-2467.
41. Gordon JR, Galli SJ, (1994) Promotion of mouse fibroblast collagen gene expression by mast cells stimulated via the Fc epsilon RI. Role for mast cell-derived transforming growth factor beta and tumor necrosis factor alpha. J Exp Med 180: 2027-2037.
42. MacDonald AJ, Thornton EM, Newlands GF, Galli SJ, Moqbel R, et al. (1996) Rat bone marrow-derived mast cells co-cultured with 3T3 fibroblasts in the absence of T-cell derived cytokines require stem cell factor for their survival and maintain their mucosal mast cell-like phenotype. Immunology 88: 375-383.
43. Weber A, Knop J, Maurer M, (2003) Pattern analysis of human cutaneous mast cell populations by total body surface mapping. Br J Dermatol 148: 224-228.
44. Petkovic V, Moghini C, Paoletti S, Uguccioni M, Gerber B, (2004) Eotaxin-3/CCL26 is a natural antagonist for CC chemokine receptors 1 and 5. A human chemokine with a regulatory role. J Biol Chem 279: 23357-23363.
45. Pearson RD, Uydess IL, Chapman SW, Steigbigel RT, (1987) Interaction of human eosinophils with Leishmania donovani. Ann Trop Med Parasitol 81: 735-739.
46. Oliveira SH, Fonseca SG, Romao PR, Ferreira SH, Cunha FQ, (1997) Nitric oxide mediates the microbicidal activity of eosinophils. Mem Inst Oswaldo Cruz 92 (Suppl 2): 233-235.
47. Watanabe Y, Hamaguchi-Tsuru E, Morimoto N, Nishio Y, Yagyu K, et al. (2004) IL-5-Induced Eosinophils Suppress the Growth of Leishmania amazonensis In Vivo and Kill Promastigotes In Vitro in Response to Either IL-4 or IFN-gamma. DNA Cell Biol 23: 412-418.
48. Amusategui I, Sainz A, Rodriguez F, Tesouro MA, (2003) Distribution and relationships between clinical and biopathological parameters in canine leishmaniasis. Eur J Epidemiol 18: 147-156.
49. van Zandbergen G, Hermann N, Laufs H, Solbach W, Laskay T, (2002) Leishmania promastigotes release a granulocyte chemotactic factor and induce interleukin-8 release but inhibit gamma interferon-inducible protein 10 production by neutrophil granulocytes. Infect Immun 70: 4177-4184.
50. van Zandbergen G, Klinger M, Mueller A, Dannenberg S, Gebert A, et al. (2004) Cutting edge: neutrophil granulocyte serves as a vector for Leishmania entry into macrophages. J Immunol 173: 6521-6525.
51. Peters NC, Egen JG, Secundino N, Debrabant A, Kimblin N, et al. (2008) In vivo imaging reveals an essential role for neutrophils in leishmaniasis transmitted by sand flies. Science 321: 970-974.
52. Campanelli AP, Brodskyn CI, Boaventura V, Silva C, Roselino AM, et al. (2010) Chemokines and chemokine receptors coordinate the inflammatory immune response in human cutaneous leishmaniasis. Human Immunology 71: 1220-1227.
53. Cotterell SE, (1999) Leishmania donovani infection initiates T cell-independent chemokine responses, which are subsequently amplified in a T cell-dependent manner. European Journal of Immunology 29: 203-214.
54. Elshafie AI, Åhlin E, Håkansson LD, Elghazali G, Safi SHE, et al. (2011) Activity and turnover of eosinophil and neutrophil granulocytes are altered in visceral leishmaniasis. International Journal for Parasitology 41: 463-469.
55. Rousseau D, Demartino S, Anjuere F, Ferrua B, Fragaki K, et al. (2001) Sustained parasite burden in the spleen of Leishmania infantum-infected BALB/c mice is accompanied by expression of MCP-1 transcripts and lack of protection against challenge. European Cytokine Network 12: 340-347.